Washington Trust Advisors »

Revance Therapeutics shares owned by Washington Trust Advisors

Quarter-by-quarter ownership of Revance Therapeutics (RVNC) shares owned by Washington Trust Advisors from 13F filings

Historical chart of Washington Trust Advisors investment in Revance Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Revance Therapeutics held by Washington Trust Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Revance Therapeutics by Washington Trust Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $3.2k 364 8.79
2023-09-30 $2.8k 244 11.47
2023-06-30 $6.2k 244 25.31
2023-03-31 $7.9k 244 32.21
2022-12-31 $3.6k 197 18.46
2022-09-30 $5.0k 197 25.38
2022-06-30 $3.0k 197 15.23
2022-03-31 $4.0k 197 20.30
2021-12-31 $3.0k 197 15.23